alpha-aminopyridine has been researched along with Cardiomyopathy, Dilated in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benassi, A; Mattioli, G; Modena, MG | 1 |
Gillmer, DJ; Kark, P | 1 |
Coltart, DJ; Jenkins, BS; Juul, SM; Thompson, DS; Webb-Peploe, MM; Wilmshurst, PT | 1 |
Guimond, JG; Keating, D; Matuschak, GM; Meyers, F | 1 |
Büll, U; Kleinhans, E; Klepzig, M; Strauer, BE | 1 |
Coltart, DJ; Dawson, JR; Dittrich, HC; Jenkins, BS; Juul, SM; Thompson, DS; Walker, JM; Webb-Peploe, MM; Wilmshurst, PT | 1 |
6 other study(ies) available for alpha-aminopyridine and Cardiomyopathy, Dilated
Article | Year |
---|---|
Echocardiographic evaluation of cardiovascular effects of amrinone.
Topics: Adult; Aminopyridines; Amrinone; Cardiac Catheterization; Cardiomyopathy, Dilated; Cardiotonic Agents; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction | 1984 |
Dangers of amrinone.
Topics: Aminopyridines; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Heart Failure; Humans | 1984 |
Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.
Topics: Adult; Aminopyridines; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Female; Ferricyanides; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitroprusside | 1984 |
Augmentation of cardiac function in end-stage heart failure by combined use of dobutamine and amrinone.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Hemodynamics; Humans; Male; Middle Aged | 1986 |
[Amrinone in acute and long-term therapy].
Topics: Administration, Oral; Aminopyridines; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Exercise Test; Half-Life; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Long-Term Care | 1985 |
Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.
Topics: Adult; Aminopyridines; Amrinone; Angina Pectoris; Blood Pressure; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Infusions, Parenteral; Lactates; Male; Middle Aged; Vascular Resistance | 1985 |